mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.1 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.1 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.1 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.078 |
0.2 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.2 |